These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 34433495)

  • 1. Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction.
    Hoff NP; Freise NF; Schmidt AG; Firouzi-Memarpuri P; Reifenberger J; Luedde T; Bölke E; Meller S; Homey B; Feldt T; Jensen BEO; Keitel V; Schmidt L; Maas K; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Buhren BA; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; Grebe O; van Griensven M; Braun SA; Salzmann S; Rezazadeh A; Matuschek C
    Eur J Med Res; 2021 Aug; 26(1):98. PubMed ID: 34433495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees.
    Jacobson MA; Zakaria A; Maung Z; Hart C; McCalmont TH; Fassett M; Amerson E
    Clin Infect Dis; 2022 Mar; 74(4):591-596. PubMed ID: 34086881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
    Pitlick MM; Joshi AY; Gonzalez-Estrada A; Chiarella SE
    Allergy Asthma Proc; 2022 Jan; 43(1):40-43. PubMed ID: 34983709
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
    Johnston MS; Galan A; Watsky KL; Little AJ
    JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
    Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
    J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    Hippisley-Cox J; Patone M; Mei XW; Saatci D; Dixon S; Khunti K; Zaccardi F; Watkinson P; Shankar-Hari M; Doidge J; Harrison DA; Griffin SJ; Sheikh A; Coupland CAC
    BMJ; 2021 Aug; 374():n1931. PubMed ID: 34446426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    Nakashima C; Kato M; Otsuka A
    J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
    Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
    McMahon DE; Amerson E; Rosenbach M; Lipoff JB; Moustafa D; Tyagi A; Desai SR; French LE; Lim HW; Thiers BH; Hruza GJ; Blumenthal KG; Fox LP; Freeman EE
    J Am Acad Dermatol; 2021 Jul; 85(1):46-55. PubMed ID: 33838206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Delayed Large Local Reactions After the First Dose of the SARS-CoV-2 mRNA-1273 Vaccine in Japan.
    Higashino T; Yamazaki Y; Senda S; Satou Y; Yonekura Y; Imai K; Arakawa J; Kawano S; Horinosono H; Miura Y
    JAMA Dermatol; 2022 Aug; 158(8):923-927. PubMed ID: 35649530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review.
    Agustin M; Trifitriana M; Danarti R
    BMC Infect Dis; 2023 Jan; 23(1):7. PubMed ID: 36609222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
    Briggs FBS; Mateen FJ; Schmidt H; Currie KM; Siefers HM; Crouthamel S; Bebo BF; Fiol J; Racke MK; O'Connor KC; Kolaczkowski LG; Klein P; Loud S; McBurney RN
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34753828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review.
    Qaderi K; Golezar MH; Mardani A; Mallah MA; Moradi B; Kavoussi H; Shamsabadi A; Golezar S
    Dermatol Ther; 2022 May; 35(5):e15391. PubMed ID: 35194894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
    Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
    JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study.
    Alfano G; Morisi N; Fontana F; Scarmignan R; Tonelli L; Ferri C; Montani M; Melluso A; Giovanella S; Ligabue G; Mori G; Franceschini E; Guaraldi G; Cappelli G; Magistroni R; Donati G
    G Ital Nefrol; 2022 Apr; 39(2):. PubMed ID: 35470997
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyaluronic acid delayed inflammatory reaction after third dose of SARS-CoV-2 vaccine.
    Calvisi L
    J Cosmet Dermatol; 2022 Jun; 21(6):2315-2317. PubMed ID: 35384252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.